Drug intelligence / Profile preview

Colchimax

Development stage
Phase 3
Lead developer
Takeda
Modality
Small Molecules
Administration
Oral
01

Overview

Colchimax is an oral pharmaceutical drug that combines two active ingredients: colchicine and dicycloverine. It is primarily indicated for the treatment and prevention of acute gout attacks, chronic gout, and familial Mediterranean fever. Colchicine, an alkaloid, exerts its therapeutic effects by inhibiting microtubule polymerization, which in turn disrupts inflammasome activation, inflammatory cell chemotaxis, and the production of pro-inflammatory mediators like leukotrienes and cytokines. This leads to a significant anti-inflammatory action, particularly by reducing neutrophil motility and activity. Dicycloverine, an anticholinergic agent, is included to mitigate gastrointestinal side effects often associated with colchicine, such as diarrhea, by blocking acetylcholine at muscarinic receptors.

Brand names
Colchimax
02

Targets

COXNLRP3 (Nod-like receptor family pyrin domain-containing protein 3)mAChR (Muscarinic acetylcholine receptors)TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on Colchimax.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colchimax.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call